ISSN 2631-3278

About the Journal

Drugs play predominant role in human daily life and have a greater impact as well. As we witnessed many terrific diseases, it is important to design and develop new drugs on a regular basis and should be delivered safely to the targeted systems. Boffin Access journal, Drug Design Development and Delivery Journal is one such kind of source which provides new age developments and finds the significant gaps in drug development and delivery processes.

Aims and Scope

Drug Design Development and Delivery Journal mainly focus on designing of new drugs, research and developments, clinical experiments, drug delivery systems and adverse events, biochemistry and pharmacological aspects. Drug Design Development and Delivery Journal has international expert editorial board and review team and follows standard double-blind review process and making editorial decisions based on the scientific merit. The editor invites authors to submit original reports, expert reviews, opinions, policy articles, communications, editorials and letters for publication. Drug Design Development and Delivery Journal publishes quality content and paves a new platform to the clinicians, medical experts, academicians, industrial researchers, and policymakers to share and update the current knowledge.

Subjects covered by the Drug Design Development and Delivery Journal

  • Rational Drug Design
  • Molecular Docking
  • Novel therapeutic approaches to disease states
  • High-throughput screening
  • Combinatorial chemistry
  • Advances in key compound classes and therapeutic areas
  • Virtual chemistry
  • Pharmaceutical toxicology
  • Molecular Drug Design
  • Molecular Pharmacology
  • Regulatory sciences
  • In Silico Drug Design
  • Physiologically-Based Pharmacokinetic Modelling
  • Retrometabolic Drug Design
  • Structure-Based Drug Design
  • Chemical Biology Drug Design
  • Protein structure prediction and molecular simulation
  • Herbal Drug Development
  • Translational Drug Development
  • Biotechnology and nano-technology
  • Pharmacoepidemiology
  • Drug Discovery Hit to Lead
  • Drug-drug & Drug-Chemical Interactions
  • Compound Management
  • Computer-assisted Drug Design
  • Quantitative Structure Activity Relationships
  • Nano-materials in Drug Designing